A Comparison of Double-Strength Beclomethasone Dipropionate (84 μg) MDI With Beclomethasone Dipropio...
A Comparison of Double-Strength Beclomethasone Dipropionate (84 μg) MDI With Beclomethasone Dipropionate (42 μ) MDI in the Treatment of Asthma
About this item
Full title
Author / Creator
Publisher
Northbrook, IL: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Northbrook, IL: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
To compare the efficacy and safety of a double-strength formulation of beclomethasone dipropionate (BDP 84) metered-dose inhaler (MDI) with that of beclomethasone dipropionate (BDP 42) MDI in the treatment of chronic asthma.
A 28-day, randomized, double-blind, double-dummy, placebo-controlled, multicenter study.
Outpatient.
A total of 423...
Alternative Titles
Full title
A Comparison of Double-Strength Beclomethasone Dipropionate (84 μg) MDI With Beclomethasone Dipropionate (42 μ) MDI in the Treatment of Asthma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1378_chest_112_1_34
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1378_chest_112_1_34
Other Identifiers
ISSN
0012-3692
E-ISSN
1931-3543
DOI
10.1378/chest.112.1.34